Request a Proposal  

Welcome to Pharm-Olam Insights

Check out our latest white paper! We partnered with Informa Pharma Intelligence to bring you the latest information on COVID-19 and its effect on the clinical landscape.

Understanding-COVID-19_ebook_updated-0723-FINAL-1
Infectious Disease Research: Importance of Site Location in Clinical Trials

Site location plays an important role in clinical trials. The impact of location comes into play for most therapeutic areas....


(3 minute read)

Tags: Infectious Disease & Vaccines, Feasibility

Leveraging Autoimmune Therapies in Infectious Disease and Vaccine Research

The mRNA approach was first applied to cancer however has since been instrumental in the development of vaccines to protect...


(3 minute read)

Tags: Infectious Disease & Vaccines, Autoimmune

Challenges to Research in the Age of COVID

The onset of the COVID-19 pandemic has introduced a variety of challenges to “business as usual.” The virus and the ensuing...


(3 minute read)

Tags: Pharm-Olam Insights, Infectious Disease & Vaccines, COVID-19

When Will Patients Return? The COVID Impact

Managing the COVID-19 pandemic has prompted countries and regions around the world to introduce a series of adaptions. For the...


(4 minute read)

Tags: Pharm-Olam Insights, Infectious Disease & Vaccines, COVID-19

The COVID 19 Map per ClinicalTrial Gov

The COVID Pandemic is continuing to evolve. Governments and companies around the world are striving to develop vaccines and...


(8 minute read)

Tags: Infectious Disease & Vaccines, COVID-19

Pharm-Olam Releases Updated Paper on the Impact of COVID on Clinical Research

Earlier this year, Pharm-Olam partnered with Informa’s Pharma Intelligence to draft a white paper that discusses the...


(1 minute read)

Tags: Infectious Disease & Vaccines, COVID-19, Global Coverage

6 Study Adaptations to Keep Studies Moving Despite COVID-19 Pandemic

The COVID-19 Pandemic continues to evolve and fluctuate across the globe – but not evenly or predictablySome countries have...


(22 minute read)

Tags: Pharm-Olam Insights, Infectious Disease & Vaccines, Investigator Insights,

Multicenter Phase III Study Efficacy of mAb Treatment for Ventilator-Associated Pneumonia (VAP)

Pharm-Olam was hired to support a Phase 3 study of a monoclonal antibody (mAb) and its impact on patients with...


(0 minute read)

Tags: Infectious Disease & Vaccines

Join other Clinical Development experts to receive the latest industry news, trends and insights.

Subscribe to our blog and we'll give you our GDPR Controller & Processor Checklist.

GDPR_Checklist-cover